Introduction {#sec1}
============

Regulatory CBS domains are found in many important enzymes, membrane transporters, and other proteins in all kingdoms of life and in most cases bind adenine nucleotides as regulatory ligands.^[@ref1],[@ref2]^ The human genome encodes 75 CBS domain-containing proteins, and mutations in some of them are associated with hereditary diseases.^[@ref3],[@ref4]^ However, surprisingly little is known about the mechanism of CBS domain-mediated regulation, mainly because of difficulty in obtaining structural data for full-size proteins. In this regard, prokaryotic CBS domain-containing pyrophosphatase (CBS-PPase) may be a good model to study this phenomenon because it is easily accessible and stable, binds an array of adenine nucleotides, including diadenosine polyphosphates, and has a relatively simple structure; its activity can be conveniently and precisely measured. An additional merit of CBS-PPase is that its regulation through CBS domains is not complicated by other regulatory mechanisms, such as autophosphorylation in AMP-activated protein kinase^[@ref5]^ and dithiol reduction/oxidation in cystathionine β-synthase.^[@ref6]^

CBS-PPases belong to family II PPases---homodimeric Co or Mn metalloenzymes^[@ref7],[@ref8]^ with the most complex domain organization among different PPases. Each subunit of canonical family II PPase is formed by two catalytic domains, DHH and DHHA2,^[@ref9],[@ref10]^ which are supplemented by regulatory domains in CBS-PPases.^[@ref8]^ An ∼250-residue regulatory insert, found within the DHH domain, generally consists of a pair of cystathionine β-synthase (CBS) domains (a Bateman module^[@ref11]^) intercalated by a DRTGG domain. The crystal structure of the isolated regulatory insert indicates that four CBS domains belonging to two Bateman modules form a disk-like structure at the subunit interface.^[@ref12]^ By binding to the Bateman module, AMP and ADP inhibit CBS-PPase, whereas ATP and linear diadenosine polyphosphates (Ap~n~A, with *n* ≥ 4) activate it.^[@ref13],[@ref14]^ In accordance with the opposite effects of AMP and Ap~4~A on CBS-PPase activity, their complexes with the regulatory insert show significant differences in the 3D structure.^[@ref12]^ The pathways through which these structural changes propagate from the regulatory domains to the catalytic site in CBS-PPase still remain to be determined.

CBS-PPase regulation additionally involves a communication between the catalytic sites and the regulatory sites, as indicated by positive cooperativity of substrate hydrolysis (kinetic cooperativity) and monoadenosine-phosphate binding.^[@ref15]^ Accordingly, two different Michaelis and nucleotide-binding constants are required to describe the hydrolysis kinetics and its modulation by monoadenosine phosphates, respectively. Ap~4~A is unique as a regulator of CBS-PPase because it bridges two Bateman modules in the enzyme dimer^[@ref12]^ and, hence, binds noncooperatively. A less predictable effect of Ap~4~A is that it abolishes kinetic cooperativity,^[@ref14]^ which can be explained in two principally different ways: the dinucleotide either blocks communication between the catalytic sites and allows them to function independently or "silences" one active site (ultimate kinetic cooperativity). Interestingly, CBS-PPase is the only known CBS-protein regulated by diadenosine polyphosphates, acting as cellular alarmones.^[@ref16]^

Recent studies have identified two residues (Asn312 and Arg276) that are located in the DHH and CBS domains, respectively, and have a prominent role in CBS-PPase regulation and catalysis.^[@ref17],[@ref18]^ Asparagine substitution by a serine residue dramatically affects regulation by abolishing kinetic cooperativity in the absence of adenine nucleotides but restoring it in the presence of Ap~4~A.^[@ref17]^ The arginine located in the CBS2 domain has been found to control kinetic cooperativity, nucleotide-binding affinity, and the size of the regulatory signal exerted by both mono- and dinucleotides.^[@ref18]^ However, transmission of the regulatory signal from the CBS domains to a distantly located catalytic site and between subunits in CBS-PPase should involve an extended residue network that links all catalytic and regulatory sites in CBS-PPase. To identify other members of the network, we performed an extensive mutagenesis study of the subunit interface-forming CBS and DHH domains. The results reported below confirmed the proposed role of Asn312 and identified two arginine residues, Arg295 and Arg334, with a prominent role in activity regulation.

Results {#sec2}
=======

Selection of Residues for Substitution {#sec2.1}
--------------------------------------

Polar residues potentially important for signal transduction between the regulatory and active sites in *dh*PPase were selected based on two criteria: location in the contact regions of secondary structure elements and a high degree of conservation in CBS-PPases. The tertiary structures of the catalytic and regulatory parts of *dh*PPase were obtained by homology modeling using canonical *Bacillus subtilis* PPase^[@ref10]^ in the "open" conformation and the regulatory part of *cp*PPase^[@ref12]^ with bound AMP as the templates, respectively. The two parts were thereafter combined into a full-size structure ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), as described previously for *cp*PPase.^[@ref12]^ Regulatory ligand-binding residues in CBS domains generally belong to β-strands, whereas α-helices transmit the ligand-induced conformational change to catalytic domains.^[@ref1],[@ref2]^ The structural analysis suggested that helix α1 (residues 266--275) is the best candidate for signal transmission to the catalytic DHH domain. This helix interacts with the loops formed by residues 310--323 and 334--341; the former loop contains Asn312, earlier shown to be important for catalysis and kinetic cooperativity.^[@ref17]^ Next to the other side of helix α1 is Arg276, also important for allosteric regulation.^[@ref18]^

![Predicted three-dimensional structure of *dh*PPase dimer. The structure was obtained by homology modeling using the structures of canonical *B. subtilis* PPase (DHH and DHHA2 domains, PDB ID: 1 K23) and the regulatory part of *cp*PPase (CBS1, CBS2, and DRTGG domains, PDB ID: 3 L31) as the templates. The domains are shown in different colors in one subunit; the other subunit is gray. AMP molecules bound in the regulatory parts are depicted in green, and two Mn^2+^ ions bound in both active sites are shown as violet spheres. (A) The model of the whole enzyme dimer. The residues selected for replacements or replaced previously (R276) are shown in a spherical representation in the subunit colored gray. (B) A close-up view of the central part of the molecule in panel (A), with side chains of the selected residues shown as sticks.](ao9b01879_0009){#fig1}

Sequence comparison of 188 CBS-PPase sequences retrieved by a BLAST search of the NCBI Protein and KEGG GENES databases indicated high conservation in the regions suggested by the 3D model to be important for signal transduction between the CBS2 and DHH domains ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). Of note, the overall degree of conservation was smaller for the regulatory domain in comparison with the catalytic one (27 vs 49%^[@ref8]^). Based on the two criteria, six residues were selected for mutagenesis: CBS2 domain Ser266, Glu267, Lys269, and Arg295 and DHH domain Asn312 and Arg334 ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B). Residues 266, 267, and 269 belong to helix α1, and residue 295 belongs to helix α2 of the CBS2 domain. Asn312 of the DHH domain was earlier found to be involved in kinetic cooperativity (active site interaction),^[@ref17]^ and Arg334 immediately follows the invariant DHH motif (which gave name to the domain), containing two His residues directly involved in catalysis.^[@ref19]^ In some CBS-PPases, Arg334 is conservatively replaced by lysine. None of the selected residues forms contacts with the bound nucleotide in the regulatory site and substrate or metal ions in the active site.

All selected residues were replaced by alanine, and four residues were additionally subjected to more drastic (Ser/Asp, Lys/Glu, Arg/Glu) or less drastic (Lys/Arg, Arg/Lys) substitutions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Arg295 was additionally replaced by Leu, frequently found in this position in naturally occurring CBS-PPases.

###### Effects of Adenine Nucleotides on the Activities of *dh*PPase Variants Measured at 50 μM MgPP~i~ and 5 mM Free Mg^2+^[a](#t1fn1){ref-type="table-fn"}

                                                            *v*~N~/*v*                                                       
  ------------------------------------------- ------------- --------------- --------------- ----------------- -------------- -----------------
  wild type[b](#t1fn2){ref-type="table-fn"}   110 ± 4       0.037 ± 0.001   0.09 ± 0.01     2.5 ± 0.2         3.8 ± 0.1      3.32 ± 0.06
  S266A                                       85 ± 2        0.07 ± 0.02     0.23 ± 0.03     1.5 ± 0.1         1.5 ± 0.1      3.7 ± 0.1
  S266D                                       76 ± 2        0.03 ± 0.01     0.03 ± 0.01     2.5 ± 0.2         2.6 ± 0.1      3.6 ± 0.2
  E267A                                       68 ± 1        0.17 ± 0.03     0.05 ± 0.01     2.5 ± 0.2         2.7 ± 0.1      3.6 ± 0.1
  K269A                                       15 ± 0.2      0.15 ± 0.05     0.40 ± 0.07     2.8 ± 0.2         3.5 ± 0.1      3.6 ± 0.2
  K269R                                       38 ± 1        0.03 ± 0.01     0.18 ± 0.02     2.3 ± 0.3         3.0 ± 0.1      4.9 ± 0.5
  K269E                                       21 ± 1        0.016 ± 0.012   0.03 ± 0.01     2.5 ± 0.2         2.46 ± 0.07    4.9 ± 0.4
  R295A                                       0.43 ± 0.01   0.53 ± 0.02     0.47 ± 0.02     **0.63 ± 0.02**   **240 ± 20**   **0.58 ± 0.02**
  R295L                                       3.5 ± 0.1     0.36 ± 0.01     0.38 ± 0.01     **0.42 ± 0.01**   12 ± 1         **0.71 ± 0.03**
  R295E                                       3.2 ± 0.1     0.46 ± 0.01     0.23 ± 0.01     3.9 ± 0.2         **90 ± 10**    **52 ± 1**
  N312A                                       0.68 ± 0.02   0.20 ± 0.04     0.41 ± 0.05     **0.25 ± 0.05**   14 ± 2         9.7 ± 0.4
  R334A                                       5.8 ± 0.2     0.03 ± 0.01     0.38 ± 0.4      4.7 ± 0.2         11 ± 1         7.5 ± 1.0
  R334K                                       27 ± 1        0.009 ± 0.007   0.045 ± 0.007   2.5 ± 0.1         3.5 ± 0.1      4.7 ± 0.2
  R334E                                       \<0.2                                                                           

Monoadenosine and diadenosine phosphates were used at 200 and 10 μM, respectively. *v*~N~ and *v* are hydrolysis rates measured in the presence and absence of the nucleotide, respectively. Large effects are indicated by boldface.

From ref ([@ref15]).

Production and Structural Characterization of *dh*PPase Variants {#sec2.2}
----------------------------------------------------------------

Wild-type *dh*PPase and its variants were produced in *Escherichia coli* BL21(DE3) cells using the pET expression system. The recombinant proteins gave separate intense bands on SDS-PAGE analysis of cell extracts, indicating successful expression. The variant *dh*PPases were isolated from the extracts by metal affinity chromatography followed by gel filtration. As in previous isolations, the elution profile at the final purification step demonstrated two major peaks, both containing the target variant, which was in an aggregated form in the first peak. Accordingly, only the second peak was collected and used in the studies described below. Typical protein yields were approximately 10 mg/1 L cell culture, and the proteins were \>95% pure.

To estimate the effects of the substitutions on the overall structure of *dh*PPase, thermal stability of all alanine variants was measured using the SYPRO Orange dye as a probe for protein unfolding.^[@ref20]^ Five of the six variants exhibited the values of the "melting" temperature, which were derived from the fluorescence versus temperature curves ([Figure S2A](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)), similar to or greater than that for the wild-type enzyme (57 ± 1 °C) ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). One variant (K269A) demonstrated a slightly lower melting temperature (54 ± 1 °C).

Sedimentation velocity measurements of the six alanine variants indicated no significant changes in the *s*~20,w~ value ([Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)) and, hence, the oligomeric structure. The fraction of the aggregated forms with masses exceeding that for the dimer was the highest in the E267A variant (19%) and did not exceed 10% in other cases.

General Characterization of Adenine Nucleotide Effects on *dh*PPase Variants {#sec2.3}
----------------------------------------------------------------------------

AMP and ADP inhibit, whereas ATP and diadenosine polyphosphates activate wild-type *dh*PPase.^[@ref14],[@ref15]^ For the initial characterization of the variant *dh*PPases, the effects of these modulators on activity were screened at fixed concentrations that were saturating for the wild-type enzyme and a fixed concentration of the substrate (50 μM). All *dh*PPase variants retained the ability to be inhibited by AMP and ADP, although the degree of inhibition was smaller in many cases ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Most variants similarly retained their ability to be activated by ATP and diadenosine polyphosphates, with few notable exceptions. Most surprisingly, two Arg295 substitutions converted both ATP and Ap~5~A from activators into inhibitors, and the Asn312 substitution converted ATP into an inhibitor. Not less surprisingly, the degree of activation by Ap~4~A increased by two orders of magnitude upon the R295A and R295E substitutions. Activation by Ap~5~A was similarly enhanced by the R295E but not by the R295A substitution. A more detailed analysis of the effects of three nucleotides (AMP, Ap~4~A, and ATP) measured at varied nucleotide and substrate concentrations is described below. The activity of the R334E variant was quite low, and it was not characterized further.

Detailed Analysis of AMP, Ap~4~A, and ATP Effects at a Fixed Substrate Concentration {#sec2.4}
------------------------------------------------------------------------------------

In this section, we measured the effects of the three nucleotides in wide ranges of their concentrations and analyzed the results in terms of [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} and [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} with unequal *K*~N~ values for two binding sites in the enzyme dimer. We also characterized the degree of binding cooperativity with the Hill coefficient, *h*, of the empirical [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"}. The values of the ratio *K*~N1~/*K*~N2~ and *h* exceed unity for positive cooperativity and are less than unity for negative cooperativity; the expected maximal value of *h* for dimeric CBS-PPase is two, whereas the *K*~N1~/*K*~N2~ ratio may adopt any value. The advantage of the microscopic binding constants over the Hill coefficient is that they allow for a more quantitative description of the cooperativity phenomenon.^[@ref21]^ The corresponding dose dependencies for the alanine variants are presented in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, and the parameter values derived therefrom with [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} are summarized in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} (see also [Tables S3--S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf) for numerical data), along with analogous data for other variants.

![Dependences of the activities of *dh*PPase variants on (A) AMP, (B) Ap~4~A, and (C) ATP measured at 50 μM MgPP~i~ and 5 mM free Mg^2+^. Activity measured in the absence of any nucleotide was taken as unity in each curve. The lines show the best fits of [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}. Symbols for all panels are defined in panel (A). The red dashed curves refer to wild-type *dh*PPase and are taken from ref ([@ref15]) (panels (A) and (C)) or ([@ref14]) (panel (B)).](ao9b01879_0008){#fig2}

![Summary of the effects of residue substitutions on various parameters referring to *dh*PPase regulation by adenine nucleotides: (A) *A*~N~/*A*~0~, (B) (*K*~N1~*K*~N2~)^1/2^, and (C) *K*~N1~/*K*~N2~. The substituted and replacing residues are indicated in a one-letter notation at the bottom of the figure. The vertical axes are scaled logarithmically. Values measured in the presence of various nucleotides are indicated by different colors detailed at the top of the figure. Dashed horizontal lines mark the parameter level corresponding to the lack of effect (in panel (*A*)) or noncooperative binding (in panel (C)).](ao9b01879_0007){#fig3}

![Kinetic Scheme Describing Adenine Nucleotide Effects on a Dimeric Enzyme E~2~ with Two Regulatory Sites at a Constant Substrate Concentration\
N is the nucleotide, *K*~N1~ and *K*~N2~ are the microscopic nucleotide-binding constants, and *A*~0~ and *A*~N~ are the activities (*v*/\[*E*\]~0~) of the nucleotide-free and nucleotide-bound subunits, respectively. E~2~ represents the sum of substrate-free and substrate-bound enzyme forms.](ao9b01879_0003){#sch1}

All variants were inhibited by AMP ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A and [3](#fig3){ref-type="fig"}A; see also [Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)), but the inhibition index (*A*~N~/*A*~0~) was markedly elevated in some of them compared to the wild-type enzyme, consistent with the data in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} measured at a nearly saturating concentration of AMP. Most variants retained the positive AMP binding cooperativity (*K*~N1~*/K*~N2~ and *h* \> 1) observed in the wild-type *dh*PPase.^[@ref15]^ In two Arg295 replacements, cooperativity was abolished (R295A) or nearly so (R295E). Several variants (S266D, K269E, and N312A) demonstrated enhanced cooperativity, as indicated by the Hill coefficient approaching its upper limit for a homodimeric enzyme. The midpoint AMP concentration on the binding curve (√*K*~N1~*K*~N2~) was greatly reduced in the R295A and R295L variants but elevated in the R295E variant.

The effects of Ap~4~A on activity were characterized in a similar way. The limiting values of the activation index (*A*~N~/*A*~0~), obtained by extrapolating activity measured at 50 μM substrate to an infinite Ap~4~A concentration ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A; see also [Table S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)), did not differ significantly from the *v*~N~/*v* values found in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, indicating that the 10 μM Ap~4~A concentration used in the latter case was saturating or nearly so. Indeed, the *K*~N~ values for all *dh*PPase forms lie in the submicromolar range. Ap~4~A activated all variant *dh*PPases (*A*~N~/*A*~0~ \> 1), but five variants (R295L, N312A, R334A, R295A, and R295E in particular) were activated to a much greater extent in comparison to the wild-type enzyme. In all cases, Ap~4~A binding appeared to be noncooperative; small apparent deviations in *K*~m1~*/K*~m2~ and *h* from unity may be associated with the tightness of binding, which required the use of very low Ap~4~A concentrations, making the activity assay less accurate.

ATP effects were analyzed for only three variants that demonstrated a reversal of the modulation from activation to inhibition in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. The corresponding dose dependences of the inhibition are shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}C, and the results of their analysis are summarized in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} (see also [Table S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). Both Arg295 replacements reversed the ATP-binding cooperativity from positive to negative and slightly tightened ATP binding in terms of √*K*~N1~*K*~N2~. The N312A variant, whose activity was most sensitive to ATP ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), retained the positive binding cooperativity of the wild-type enzyme.

Effects of the Substitutions on Kinetic Cooperativity in the Absence and Presence of AMP, Ap~4~A, and ATP {#sec2.5}
---------------------------------------------------------------------------------------------------------

Rate dependences on substrate concentration for wild-type *dh*PPases and the majority of its variants demonstrated deviations from the Michaelis--Menten equation, that is, "kinetic cooperativity", which could be adequately described in terms of [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"} and [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"} with unequal *K*~m~ values for two active sites in the enzyme dimer ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). The degree of the kinetic cooperativity was similarly characterized by the ratio *K*~m1~/*K*~m2~ and the Hill coefficient, *h* (values of the latter parameter are found in [Table S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)).

![Dependences of the activities of *dh*PPase variants on substrate concentration measured at 5 mM free Mg^2+^. The lines show the best fits of [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}. The red dashed curve refers to wild-type *dh*PPase and is taken from ref ([@ref15]).](ao9b01879_0006){#fig4}

![Kinetic Scheme for the Reaction Catalyzed by a Homodimeric Enzyme E~2~ with Two Active Sites at a Zero or Fixed Nucleotide Concentration\
S is the substrate, *K*~m1~ and *K*~m2~ are the Michaelis constants, and *k*~cat~ is the catalytic constant for each active site.](ao9b01879_0002){#sch2}

Based on these criteria, wild-type *dh*PPase exhibits appreciable positive kinetic cooperativity (*K*~m1~/*K*~m2~ = 10, *h* = 1.29).^[@ref15]^ The replacements of Ser266, Glu267, Lys269, and Arg295 had only small effects on the cooperativity, whereas the replacements of Asn312 and Arg334 abolished or markedly decreased it ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A; see also [Table S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). There was no obvious correlation between the effects on cooperativity and individual *K*~m~ values; however, *K*~m2~ was more frequently affected. The largest effect on the mean *K*~m~ value (√*K*~m1~*K*~m2~) was observed with the R295A and R295E variants. According to the effects on *k*~cat~, the variants can be divided into two groups, that is, those with large effects (boldfaced in [Table S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)) and those with small or moderate effects. For two residues (Arg295 and Arg334), the effect on *k*~cat~ strongly depended on the replacing residue.

![Summary of the effects of residue substitutions on various parameters describing MgPP~i~ hydrolysis by *dh*PPase in the absence and presence of adenine nucleotides: (A) *k*~cat~, (B) (*K*~m1~*K*~m2~)^1/2^, and (C) *K*~m1~/*K*~m2~. The substituted and replacing residues are indicated in a one-letter notation at the bottom of the figure. The vertical axes are scaled logarithmically. Bars showing the values that exceeded the ordinate range in panel (C) end with arrows. Values measured in the presence of various nucleotides are indicated by different colors detailed at the top of the figure. Dashed horizontal lines mark the parameter level for nucleotide-free wild-type *dh*PPase (panels (A) and (B)) or for noncooperative kinetics (panel (C)).](ao9b01879_0005){#fig5}

In the second set of experiments, we evaluated the effect of fixed concentrations of AMP, Ap~4~A, and ATP on the dependences of activity on substrate concentration ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). This type of experiment with AMP could be performed only with the variants showing reasonably high AMP-binding affinity and a high *A*~N~/*A*~0~ ratio ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}; see also [Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)) because otherwise the nucleotide-free enzyme, present at equilibrium with the nucleotide-bound enzyme, would contribute significantly to the measured activity. ATP effects were again analyzed for the three variants that demonstrated a reversal of the modulation effect in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

The results of this analysis indicate that AMP decreased the *k*~cat~ value for all variants ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A; see also [Table S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)), that is, it acted as an inhibitor. The effects of AMP on the midpoint substrate concentration on activity versus the \[MgPP~i~\] profile (√*K*~m1~*K*~m2~) were not uniform ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}B; see also [Table S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)): in most variants, AMP increased √*K*~m1~*K*~m2~, that is, it also acted as an inhibitor, but in the R295A, R295E, and N312A variants, AMP decreased √*K*~m1~*K*~m2~ several fold, that is, it acted as an activator. It should be noted, however, that the activating effect of AMP on the three latter variants only partially compensated for the much larger effects on *k*~cat~, which made AMP an inhibitor at any substrate concentration. Interestingly, AMP abolished positive kinetic cooperativity in one variant (R295E) and changed it to slightly or moderately negative in four variants (E267A, R295A, N312A, and R334A) ([Table S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)).

The effects of Ap~4~A on the substrate concentration dependences of activity indicated that Ap~4~A increased the *k*~cat~ value of all variants, except for S266A, by a factor varying from 1.3 to 45 ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A and [Table S8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). The effects of Ap~4~A on the √*K*~m1~*K*~m2~ values were also favorable for activity, except for the R295A, R295L, and N312A variants, and varied from 7- to 36-fold, that is, it also markedly exceeded the effect on the wild-type enzyme (a 2.4-fold decrease in √*K*~m1~*K*~m2~). As a combined result of the effects of Ap~4~A on *k*~cat~ and √*K*~m1~*K*~m2~, the activities of the R295A and wild-type enzymes measured with 50 μM substrate in the presence of Ap~4~A were similar, although their activities measured in the absence of Ap~4~A differed by a factor of 250 ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

A remarkable effect of Ap~4~A on the wild-type *dh*PPase was the abolishment of kinetic cooperativity.^[@ref14]^ This property was retained in a half of the variants, whereas the other half demonstrated positive kinetic cooperativity ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C), the degree of which generally exceeded that demonstrated by the wild-type enzyme in the absence of any nucleotide. For two Arg295 replacements, the Hill coefficient even reached its limiting value for a dimeric enzyme ([Table S8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)).

ATP reversed kinetic cooperativity only in the R295A variant, while two other tested variants (R295L and N312A) retained the positive cooperativity of the wild-type enzyme ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C; see also [Table S9](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). ATP activation of the wild-type enzyme resulted from favorable changes in both *k*~cat~ (an increase) and √*K*~m1~*K*~m2~ (a decrease). In the R295L variant, the ATP effects on both parameters were unfavorable for activity, whereas in the two other variants, ATP induced an unfavorable change in one parameter and a favorable change in the other. Of note, the R295A variant was inhibited by ATP at any substrate concentration because the unfavorable effect on *k*~cat~ exceeded that of the favorable effect on √*K*~m1~*K*~m2~, whereas the N312A variant was slightly activated in saturating conditions but inhibited at low substrate concentrations (compare the N312A curves in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and [Figure S3C](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)).

Modeling and MD Simulations {#sec2.6}
---------------------------

We have previously modeled a three-dimensional structure of an N77S variant of canonical family II PPase from *B. subtilis*([@ref17]) to understand why a corresponding mutation (N312S) abolished active site interaction (kinetic cooperativity) in *dh*PPase. The modeled structure contained a bound substrate analogue, imidodiphosphate, in only one subunit to mimic the state at which substrate binding cooperativity is manifested. Here, we performed the same modeling for the N77A variant of *B. subtilis* PPase. The modeled structure ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B) indicated an even more drastic change in the H-bonding pattern of the loop formed by residues 96--109 at the subunit interface. The replacement predictably caused loss of all intrasubunit bonds of the residue 77 side chain. As a consequence, only three intersubunit H-bonds were detected with the program Hbonanza^[@ref22]^ using default settings in the N77A variant---between Arg99 and Thr105′ (Nε2···O), between Asn102 and Phe103′ (N···O), and between Thr105 and Ile100′ (Oγ···N) ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B) compared with eight such H-bonds present in the wild-type enzyme ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A).

![Hydrogen bonding of loop 96--109 and nearby residues at the subunit interface in the simulated structures of (A) the wild-type *B. subtilis* PPase and (B) its N77A and (C) R99A variants, corresponding to *dh*PPase N312A and R334A variants. The H-bonds shown were observed in more than 50% of snapshots saved during the 650--700 ns interval. The solid line separates subunits A and B. The imidodiphosphate (PNP) molecule (orange sticks) and four Mg^2+^ ions (green spheres) are bound in the active site of subunit A; subunit B contains only two Mg^2+^ ions (not shown). The figure in panel (A) was taken with permission from ref ([@ref17]).](ao9b01879_0004){#fig6}

Modeling was also performed for the *B. subtilis* PPase R99A variant, which corresponds to the R334A variant of *dh*PPase used in this study. Unlike Asn77, Arg99 interacts directly with the other subunit. Again, only three intersubunit H-bonds were detected ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}C), but they differed from those in the N77A variant. These H-bonds included those between Ile100 and Thr105′ (N···Oγ and O···N) and between Phe103 and Ile100′ (N···O). Interestingly, Asn77 lost most of its intrasubunit H-bonds as a result of the R99A substitution, resembling the effects of the N77A substitution. Thus, these two mutations similarly destabilized the contact region of the DHH domains in *B. subtilis* PPase.

Both simulated structures slightly differed from the crystal structure of the wild-type enzyme ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). However, the differences were of the same size as observed previously for wild-type *bs*PPase^[@ref17]^ and seemingly result from structural distortions of the crystalline state.

Discussion {#sec3}
==========

The regulatory and catalytic sites are separated in space in CBS-PPase ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Therefore, signal transfer between the sites requires coordinated movements of multiple amino acid residues. In terms of the "induced-fit" concept,^[@ref23]^ the resting regulatory site does not perfectly fit the nucleotide molecule to be bound, so the binding event involves the displacement of protein ligands to establish all interactions with the nucleotide. To generate a regulatory signal, part of these interactions should act like a loaded spring and hence destabilize the complex. As a corollary, replacement of the corresponding amino acid residue with a neutral one, like alanine, should (a) stabilize the complex and (b) suppress or cancel regulation. Furthermore, this "spring" should extend to the active site to transmit the regulatory signal to its destination, and hence, the above predictions are also valid for all spring-forming residues. None of the residues substituted in this study is a nucleotide ligand, disallowing direct inferences on where the spring starts. However, the data in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A,B identify two intermediate residues with the predicted effects of the mutation---Arg295 and Asn312. Indeed, the mutation of Arg295 to Ala or Leu decreased the mean binding constant, √*K*~N1~*K*~N2~, for AMP by approximately 20-fold and increased the residual activity of the AMP complex 5--10-fold. These mutations exerted similar, although smaller effects on the strength of ATP binding, cancelling or even reversing its activating effect ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A). The Asn312A replacement had similar effects on the binding of AMP and ATP and their modulating effects on activity ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A,B). The correlation between the effects of the substitutions on the regulation by AMP and ATP suggests that ligand-mediated inhibition and activation are transmitted through the same residues. One can further speculate that the inhibiting nucleotides increase the strain in the spring, whereas the activating nucleotides partially release it.

Our previously published data on the N312S variant of *dh*PPase^[@ref17]^ are fully consistent with these inferences. The substitution decreased √*K*~N1~*K*~N2~ for AMP binding by approximately 4-fold and increased the residual activity of the complex by 10-fold. In contrast, the R276A substitution increased the residual activity of the AMP complex by 13-fold,^[@ref18]^ as expected for a spring-forming residue, but had a different effect on √*K*~N1~*K*~N2~ for AMP (a 12-fold increase). Similar effects on AMP binding and regulation were previously observed upon R168A and R187G substitutions in the DRTGG domain-lacking *Moorella thermoacetica* CBS-PPase,^[@ref24]^ wherein Arg168 and Arg187 correspond to *dh*PPase Arg276 and Arg295, respectively.

Regulation of CBS domain-containing enzymes and transporters by nucleotides is attributed to their modulation of the internal inhibition imposed by the CBS domains on protein function.^[@ref25]^ Several lines of evidence support this concept in the case of CBS-PPase. They include the findings that CBS-PPases exhibit a diminished activity (by one to three orders of magnitude) compared with their close homologues lacking CBS domains^[@ref26]^ and that nucleotides may inhibit (AMP and ADP) or activate (ATP and diadenosine polyphosphates) this enzyme. Furthermore, several mutations in CBS domains activated CBS-PPase of *M. thermoacetica* and some even reversed the effect of nucleotide from inhibition to activation,^[@ref24]^ resembling the effects of mutations in cystathionine β-synthase^[@ref27]^ and AMP-dependent protein kinase.^[@ref28],[@ref29]^ Finally, deletion of the regulatory domains in *dh*PPase favorably changed (decreased) its *K*~m~ values.^[@ref15]^

The results of this study support and further extend the concept of internal inhibition induced in CBS-PPase by the regulatory insert. In terms of the mechanical model of CBS-PPase regulation, internal inhibition is caused by a strain at the interface of the regulatory and catalytic domains, which is transmitted to the active site and distorts it. The pathways through which the signals from the regulatory insert itself and bound nucleotides reach the active site seem both involve Arg295 and Asn312 and hence overlap, at least partially. This inference comes from the finding that Arg295 modifications suppressed catalytic activity by two orders of magnitude and simultaneously enhanced its activation by Ap~4~A, such that the activity of the Ap~4~A-activated R295A and R295E variants was comparable with the activity of the wild-type enzyme. Of note, these findings add to the knowledge that, despite the low activity of the variant enzymes, the substitutions did not disrupt the protein structure. Apparently, the substitutions aggravated the internal inhibition by CBS domains, but this effect was largely reversed by Ap~4~A binding. Furthermore, we found that the removal of the charged side chain in Arg295 or the polar side chain in Asn312 converted ATP from an activator to an inhibitor. The Arg295 modification similarly reversed the activating effect of Ap~5~A ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

Cooperativity of monoadenosine phosphate binding suggests that another spring joins the CBS domains of two subunits in dimeric CBS-PPase. DRTGG domains do not appear to be involved in nucleotide-binding cooperativity, as this has also been exhibited by the CBS-PPases, which lack DRTGG domains in their structures.^[@ref15]^ Only Arg295 but not Asn312 or any other replaced residue is involved in this type of cooperativity, as it was appreciably suppressed or, ultimately, reversed only upon the removal of the Arg295 guanidino group ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C). In contrast, replacements of Asn312 (N312A and N312S) dramatically increased the cooperativity of AMP binding ([Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf) and ref ([@ref17])), which may mean that Asn312 interactions counteract this type of cooperativity. The effect of the Asn312 substitutions on ATP binding was much smaller, if any ([Table S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)). Ap~4~A bound noncooperatively in wild type and all variant *dh*PPases, consistent with its binding stoichiometry of 1 mole/mole dimer.^[@ref12],[@ref14]^

Yet another spring connects active sites in CBS-PPase, causing positive kinetic cooperativity, as manifested by the decreased Michaelis constant for the second bound substrate molecule. We found earlier that this type of cooperativity was eliminated by the N312S substitution.^[@ref17]^ The importance of Asn312 for kinetic cooperativity is supported by the N312A data ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C). Consistent with this, the N312A variant exhibited a lower mean Michaelis constant (√*K*~m1~*K*~m2~) in comparison with the wild-type enzyme ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}B). Furthermore, our new data suggest that Arg334 also plays a role in kinetic cooperativity, as R334A substitution also made the hydrolysis kinetics noncooperative ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C), despite the fact that it did not decrease √*K*~m1~*K*~m2~. One should keep in mind that this parameter is a combination of rate constants, rather than a binding constant, and its increase does not necessarily imply the increased strain on the spring.

A surprising effect of Ap~4~A was to eliminate or greatly decrease kinetic cooperativity in different CBS-PPases^[@ref14]^ and the *dh*PPase variants with substituted Ser266, Glu267, and Lys269 residues ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C). This may mean that the cross-linking Ap~4~A molecule fixes the active site-connecting spring in one position or completely relaxes it, for instance, by disrupting the contact between the catalytic DHH domains. In a sharp contrast, Ap~4~A induced a very high positive kinetic cooperativity in the variants with substituted Arg295 and Asn312 residues and less so in the Arg334 variants ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C). A likely corollary is that a cross-linking Ap~4~A molecule somehow restores intersubunit contact through DHH domains or replaces it in the variants with substituted Asn312 and Arg334 residues. However, these interpretations may be inappropriate with the Arg295-substituted variants, as they retained kinetic cooperativity in the absence of nucleotides ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C). Further structural studies are clearly needed to explain the opposite effects of Ap~4~A on kinetic cooperativity in different variants.

The following note is appropriate at the point. A classical view of allosteric effects, including binding cooperativity, implies a conformational change induced by ligand binding to a remote site. However, an increasing body of evidence supports a different, entropic concept that relies upon changes in the dynamic fluctuations about the mean conformation with no change in the mean conformation itself.^[@ref30],[@ref31]^ A combination of the "conformational" and "entropic" mechanisms is also possible. Our mechanical description of cooperativity is applicable to both mechanisms, depending to what is assumed to load "springs"---static displacements of atoms or changes in their dynamic behavior.

Because the substrate itself binds cooperatively to CBS-PPase in the absence of nucleotides, the apparent nucleotide binding cooperativity, which was also inferred from activity measurements, might be induced by the bound substrate or by nucleotide-mediated modulation of substrate binding. However, lack of correlation between the effects of the mutations on kinetic and nucleotide binding cooperativities ([Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C and [5](#fig5){ref-type="fig"}C) apparently refutes such a mechanism. The absence of a causative link between the cooperativities of binding to two types of sites in CBS-PPase is also consistent with the previous finding that the AMP- and ATP-binding cooperativity in *dh*PPase does not depend significantly on substrate concentration.^[@ref15]^

[Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} summarizes the functional consequences of all heretofore described substitutions in the CBS and DHH domain residues that were deemed important for the regulation of CBS-PPase. These data identify four residues that are indeed important: arginines 276, 295, and 334 and asparagine 312. Substitutions of two of these residues, Arg295 and Asn312, affected practically all parameters associated with the three regulatory signal pathways connecting the active sites, the regulatory sites, and the regulatory and active sites. Noteworthy, *Ethanoligenens harbinense* CBS-PPase, which has leucine and serine in the positions corresponding to *dh*PPase Arg295 and Asn312, respectively, is not regulated by adenine nucleotides and exhibits no kinetic cooperativity.^[@ref17]^ Furthermore, these residues appear to be involved in the internal inhibition imposed by the regulatory domains in the absence of nucleotides. Arg334, like the previously explored Arg276,^[@ref18]^ is essential for signal transduction between the catalytic domains of different subunits. However, Arg334 differs from Arg276 in that it is not involved in signal transduction between the regulatory and catalytic domains within one subunit, as Arg334 substitution with alanine did not appreciably change the effects of nucleotides on activity. Noteworthy, positions 295, 312, and 334 are almost invariant or, rarely, conservatively replaced in hundreds of CBS-PPase sequences ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf)).

###### Summary of the Effects of the Residue Substitutions on the Regulatory Properties of *dh*PPase[a](#t2fn1){ref-type="table-fn"}

                                          kinetic cooperativity   Michaelis constants   nucleotide-binding cooperativity   nucleotide-binding affinity   degree of inhibition/activation                                  
  --------------------------------------- ----------------------- --------------------- ---------------------------------- ----------------------------- --------------------------------- ---- ----- ---- ---- ---- ---- ----
  S266A                                   --                      --                    --                                 --                            --                                --   --    --   --   --   --   --
  S266D                                   --                      ?                     --                                 --                            --                                --   --    --   --   --   --   --
  E267A                                   --                      ++                    --                                 --                            --                                --   --    --   --   --   --   --
  K269A                                   --                      --                    --                                 \+                            --                                --   --    --   --   --   --   --
  K269R                                   --                      ?                     --                                 --                            ?                                 --   --    \+   --   --   --   --
  K269E                                   --                      ?                     --                                 --                            ?                                 --   \+    --   \+   --   --   --
  R276A[b](#t2fn2){ref-type="table-fn"}   ++                      ++                    ++                                 \+                            ++                                --   --    ?    --   --   \+   \+
  R276K[b](#t2fn2){ref-type="table-fn"}   \+                      ++                    ++                                 --                            \+                                --   --    --   --   --   --   --
  R276E[b](#t2fn2){ref-type="table-fn"}   --                      --                    \+                                 \+                            --                                --   \+    --   \+   --   --   --
  R295A                                   --                      ++                    ++                                 \+                            --                                ++   ++    --   ++   \+   ++   ++
  R295L                                   --                      --                    ++                                 --                            --                                ++   ++    --   \+   \+   ++   --
  R295E                                   --                      ++                    \+                                 \+                            --                                --   +--   --   --   \+   \+   ++
  N312A                                   ++                      ++                    ++                                 \+                            ++                                \+   \+    --   \+   \+   ++   --
  N312S[c](#t2fn3){ref-type="table-fn"}   ++                      ++                    ++                                 \+                            ++                                --   \+    --   \+   ++   ++   \+
  R334A                                   ++                      ++                    \+                                 --                            --                                --   --    --   --   \+   --   --
  R334K                                   --                      ?                     ++                                 ?                             --                                --   --    --   --   --   --   --

A minus sign (−) indicates small or no effect, plus sign (+) indicates a large effect, two plus signs (++) indicate a profound effect, and question mark (?) indicates lack of information. Columns marked as N, M, and D refer to the effects measured without any nucleotide, in the presence of the mononucleotides, and in the presence of the dinucleotides, respectively.

From ref ([@ref18]).

From ref ([@ref17]).

Modeling and MD simulation experiments on *B. subtilis* PPase, which contains only catalytic DHH and DHHA2 domains in its structure, provided a likely structural explanation for the roles of Asn312 and Arg334 in kinetic cooperativity in *dh*PPase. These experiments indicate that replacements with alanine of the corresponding Asn77 and Arg99 residues destabilize subunit contact through the DHH domains ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}), thus hampering signal transfer between active sites. Modeling the behavior of the Arg295-substituted variants could not be performed in the same way because Arg295 belongs to the CBS domain, not found in *B. subtilis* PPase. It is unlikely that the effect of Arg295 substitution is also associated with the modification of DHH--DHH contact because the Arg295-substituted variants exhibited positive kinetic cooperativity in the absence of adenine nucleotides ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}C). In the structure of the regulatory part of *C. perfringens* CBS-PPase, the guanidino group of the corresponding Arg296 residue forms four H-bonds with other residues, and their disruption by R/A or R/L mutation may have an unpredictable effect on the enzyme structure and function.

In conclusion, our data define the roles for two amino acid residues, Arg295 and Arg334, as important in the activity regulation of CBS-PPase and support the previously assigned role of Asn312 in regulation. In more general terms, the results of this study attest to the usefulness of CBS domain-containing pyrophosphatase as a model enzyme to study the general principles of protein regulation via CBS domains, at the same time emphasizing a critical requirement for the structure of a full-size enzyme for further progress.

Experimental Section {#sec4}
====================

Materials {#sec4.1}
---------

Wild-type *dh*PPase (UniProtKB: B8FP42) and its variants containing a His~6~ tag at their N-termini were isolated from *E. coli* BL21 cells transformed with the pET-28b vector (Novagen) carrying the corresponding gene, as described previously.^[@ref18]^ Site-directed mutagenesis was performed using overlap extension PCR with Phusion DNA polymerase. The purity of the final products was estimated by SDS-PAGE^[@ref32]^ with Coomassie staining. Protein concentrations were determined spectrophotometrically, using an *A*^0.1%^~280~ value of 0.477, as calculated from the amino acid composition with ProtParam. Molar concentrations were calculated on the basis of a subunit molecular mass of 62.5 kDa for the His~6~-tagged protein.

AMP (free acid), ADP (diammonium salt), ATP (disodium salt), Ap~4~A (ammonium salt), and Ap~5~A (pentasodium salt) were obtained from Sigma-Aldrich. The concentrations of nucleotide stock solutions were estimated by measuring absorbance at 259 nm (ε = 15,900 M^--1^ cm^--1^ for the mononucleotides and 31,800 M^--1^ cm^--1^ for the dinucleotides).

Kinetic Assays {#sec4.2}
--------------

The activity assay medium contained 5 mM free Mg^2+^ ion (added as MgCl~2~), 50 μM MgPP~i~ complex (added as tetrasodium PP~i~), and 0.1 M Tes-KOH or Mops-KOH buffer, pH 7.2, except where specified otherwise. Reactions were initiated by adding an enzyme, and P~i~ accumulation due to PP~i~ hydrolysis was continuously recorded for 2--3 min at 25 °C using an automated P~i~ analyzer^[@ref33]^ at a sensitivity of 4--20 μM P~i~ per recorder scale. Initial velocity values were proportional to enzyme concentration and generally agreed within 5--10% in replicate measurements.

Bioinformatics Analysis {#sec4.3}
-----------------------

CBS-PPase protein sequences were retrieved by BLAST from the NCBI Protein^[@ref34]^ and KEGG GENES^[@ref35]^ databases. Protein sequences were aligned with ClustalX (version 2.1) using default settings. The alignment was manually processed by eliminating incomplete and redundant sequences and sequence regions that included indels and ambiguously aligned residues. Protein structures were visualized and analyzed using UCSF Chimera.^[@ref36]^

ThermoFluor Measurements^[@ref20]^ {#sec4.4}
----------------------------------

Thermostability measurements were performed using a C1000 thermal cycler with the CFX96 real-time PCR detection system (Bio-Rad). The assay mixtures with a total volume of 50 μL, placed in transparent low-profile 96-well multiplate PCR plates (SSIbio), contained 5--8 μM enzyme, 0.02% SYPRO Orange dye (Invitrogen), 0.1 M Mops-KOH buffer, pH 7.2 (measured at 25 °C), 2 mM MgCl~2~, 0.1 mM CoCl~2~, and 150 mM KCl. The plates were closed with an UltraFlux Standard PCR sealing film (SSIbio) and heated from 30 to 100 °C with stepwise increments of 0.5 °C and a 20 s hold step for every point. Fluorescence was monitored at 552 nm (second channel, VIC filter), and melting temperatures, *T*~m~, were determined from the resulting curves with CFX Manager software.

Sedimentation Analysis {#sec4.5}
----------------------

Analytical ultracentrifugation was performed at 25 °C in a Spinco E instrument (Beckman Instruments) equipped with a computerized data collection unit, with scanning at 280 nm. Samples contained 10--20 μM CBS-PPase, 0.1 M Mops/KOH buffer, pH 7.2, 2 mM MgCl~2~, 0.1 mM CoCl~2~, and 150 mM KCl. Prior to each run, samples were incubated for 6 h at 25 °C. The sedimentation velocity was measured at 60,000 rpm, and sedimentation coefficients (*s*~20,w~) were calculated with the program SedFit.^[@ref37]^

Molecular Dynamics (MD) {#sec4.6}
-----------------------

Virtual mutations and molecular dynamics (MD) simulations with dimeric canonical *B. subtilis* PPase, which lacks the regulatory CBS-DRTGG-CBS insert, were carried out essentially as described previously.^[@ref17]^ MD simulations were performed using the PMEMD program (CUDA implementation) of the AMBER 14 software suite with the ff14SB force field (<http://ambermd.org/>). The 8 Å cutoff production MD simulation was performed for 750 ns for each variant protein, with snapshots saved every 10 ps. Post-processing trajectory analyses were carried out with the program CPPTRAJ of the AMBER 14 pack.

Data Analysis and Calculations {#sec4.7}
------------------------------

Nucleotides effects on activity at a fixed substrate concentration were analyzed in terms of [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, written in terms of microscopic binding constants, like in our latest publication.^[@ref18]^ Use of microscopic constants simplified analysis in comparison to the use of macroscopic constants in previous analyses^[@ref14],[@ref15],[@ref17]^ without effect on its results. The microscopic and macroscopic binding (and Michaelis) constants are linked by the following relationships: *K*~N1(micro)~ = 2*K*~N1(macro)~, *K*~N2(micro)~ = 0.5*K*~N2(macro)~.^[@ref38]^ The dependences of the hydrolysis rate (*v*~N~) on nucleotide concentration (\[N\]) were fit to [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}.^[@ref18]^ In the framework of [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, binding cooperativity can be diagnosed by comparing the *K*~N~ constants: *K*~N1~ \> *K*~N2~ indicates positive cooperativity, *K*~N1~ \< *K*~N2~ indicates negative cooperativity, and *K*~N1~ = *K*~N2~ is indicative of noncooperative behavior. Decreases in the free nucleotide concentration because of binding to the enzyme could be neglected in all cases, except for the pair R295A variant/Ap~4~A. In the latter case, [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"} was fitted to the binding data together with mass balance equations for the enzyme and nucleotide. According to [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}, the midpoint of the *v/*\[E\]~0~ versus \[N\] profile is achieved at nucleotide concentration equal to √*K*~N1~*K*~N2~.

The cooperative kinetics of substrate (MgPP~i~) hydrolysis is described by [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, which assumes different microscopic Michaelis constants (*K*~m1~ and *K*~m2~) and equal *k*~cat~ values for two active sites in the dimer (K-type kinetic cooperativity).^[@ref38]^ The rate equation for [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"} is given by [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}, where *v* is the reaction rate, and \[*E*\]~0~ and \[*S*\] are the total enzyme and substrate concentrations, respectively.^[@ref18]^ As in the case of nucleotide binding, *K*~m1~ \> *K*~m2~ implies positive and *K*~m1~ \< *K*~m2~ implies negative kinetic cooperativity. According to [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}, half-maximal activity is achieved at a substrate concentration equal to √*K*~m1~*K*~m2~.

Alternatively, rate dependences on substrate and nucleotide concentrations were fit to [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"}where *h* is the Hill coefficient, L is S or N, and *v*~L~ is the rate at infinite \[L\].

The total concentrations of MgCl~2~ and PP~i~ required to maintain desired concentrations of MgPP~i~ (actual substrate) and 5 mM free Mg^2+^ ion in the activity assay mixture at pH 7.2 were calculated taking into account the following magnesium complexes: MgPP~i~, Mg~2~PP~i~, MgAMP, MgADP, and MgATP.^[@ref18]^ Nonlinear least-squares fittings were performed using the program Scientist (Micromath).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b01879](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b01879).Plots of sequence alignments, ThermoFluor titration data, and substrate concentration dependences of activity and numerical data used to construct bar plots describing effects of the amino acid replacements on catalysis by and regulation of *D. hafniense* pyrophosphatase ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01879/suppl_file/ao9b01879_si_001.pdf))
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